Bing Z. Carter

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

36h-index4.1kcitations262works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(105), Cell death mechanisms and regulation(62), MicroRNA in disease regulation(45), RNA Interference and Gene Delivery(41), Chronic Myeloid Leukemia Treatments(36)

Publications262 total

Overcoming Menin inhibitor resistance in AML cells with combinations including BET proteins and dual BRG1/BRM inhibitor
Blood·2026
Outcomes of therapy‐related non‐core binding factor acute myeloid leukemia with venetoclax‐based therapies
HemaSphere·2026Open Access
Supplementary Table S1 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S4 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S3 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S2 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Table S5 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Methods from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Supplementary Figures 1-7 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
2025Open Access
Menin inhibitor DS-1594b drives differentiation and induces synergistic lethality in combination with venetoclax in acute myeloid leukemia cells with rearranged mixedlineage Leukemia and mutated nucleophosmin-1
Haematologica·2025· 1 citedOpen Access
Abstract 553: Drp1 knockdown impairs mitophagy and sensitizes AML cells to venetoclax by inducing apoptosis
Cancer Research·2025
Abstract 4306: KMT2A rearranged acute myeloid leukemia is vulnerable to the combinatorial inhibition of menin and MYC protein degradation
Cancer Research·2025
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation
International Journal of Biological Macromolecules·2024· 1 citedOpen Access
Targeting Co-Regulatory Feedback Loop of MYC and GSPT1 By MYC/GSPT1 Dual Degradation Is Synthetic Lethal in Combination with Ven/Aza in TP53 Mutant Acute Myeloid Leukemia Stem and Progenitor Cells
Blood·2024· 2 citedOpen Access
Reactivation of p53 in <i>TP53</i>-Y220C Mutant AML: Mechanism of Action and Mechanism-Based Drug Combinations
Blood·2024
Supplementary Methods from Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia
2024Open Access
Supplementary Table S3 from Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia
2024Open Access
Supplementary Table S4 from Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia
2024Open Access
Supplementary Table S1 from Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia
2024Open Access
Supplementary Figures 1-7 from Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia
2024Open Access
page 1 of 14Next →

Frequent Co-authors

Michael Andreeff(35), Duncan H. Mak(20), Po Yee Mak(15), Wendy Schober(11), Marina Konopleva(11), Steven M. Kornblau(9), Vivian Ruvolo(9), Hong Mu(7), Jörge E. Cortes(7), Wenjing Tao(7), Hagop M. Kantarjian(6), Teresa McQueen(5), Michèle Milella(5), Lauren B. Ostermann(5), Xuelin Huang(4), John C. Reed(4), Kevin R. Coombes(4), Xuejie Jiang(4), Jo Ishizawa(4), Zeev Estrov(3)